This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Post partum psoriasis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • prevalence in pregnant women is unknown - probably reflects that of non-pregnant women of child bearing age
  • psoriasis in pregnancy
    • chronic plaque psoriasis improves in 40-60% of patients during pregnancy
      • most improvement during the late first and second trimesters
    • psoriasis deteriorates in 10-20% of women during pregnancy
  • poriasis and pregnancy related morbidity:
    • does not affect fertility or rates of miscarriage, birth defects, or premature birth
    • psoriasis is associated with depression - however no evidence that pregnancy exacerbates depression more in patients with psoriasis than in the normal population
    • various treatments for psoriasis are contraindicated in pregnancy
  • treatment of psoriasis in pregnancy:
    • topical treatments are first line treatments for psoriasis
      • emollients, topical steroids, and dithranol are considered safe in pregnancy
      • manufacturers of vitamin D analogues such as calcipotriol advise that these agents should be avoided in pregnancy
        • however it unlikely that significant systemic absorption will occur when they are used for localised disease
      • coal tar products - animal studies have suggested teratogenicity, although this has not been reported in humans
        • such products are probably safe for use in the second and third trimesters (1)
      • consider referral to a dermatologist if topical treatments fail to control disease
        • ultraviolet B (UVB) is the safest second line therapy - followed by ciclosporin
  • psoriasis in the postpartum
    • more than 50% of women have a flare-up within six weeks of delivery - however this is usually not worse than their prepregnancy state
  • psoriasis and breast feeding
    • fiirst line treatment options for breastfeeding women
      • emollients, moderate to low potency topical steroids, and dithranol
      • use of topical treatment should be after breast feeding - must be washed off thoroughly before the next feed.
    • many treatments such as acetretin, methotrexate, ciclosporin, hydroxycarbamide, biological treatments, and PUVA are all contraindicated in breastfeeding women
      • safest second-line agent is ultraviolet B
      • if first line treatment options fail to control disease then breastfeeding may need to be curtailed to increase treatment options


  1. BMJ. 2007 Jun 9;334(7605):1218-20

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.


Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.